We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$253B
AUM Growth
+$4.08B
Cap. Flow
+$937M
Cap. Flow %
0.37%
Top 10 Hldgs %
19.37%
Holding
7,530
New
489
Increased
3,007
Reduced
2,579
Closed
641

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$309M
2
ENB icon
Enbridge
ENB
+$233M
3
T icon
AT&T
T
+$219M
4
AGN
Allergan plc
AGN
+$211M
5
MET icon
MetLife
MET
+$202M

Sector Composition

Rank Sector Weight
1 Financials 21.04%
2 Technology 8.79%
3 Energy 8.22%
4 Industrials 7.49%
5 Communication Services 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SER icon
6426
Serina Therapeutics
SER
$42.7M
$1K ﹤0.01%
22
+6
+38% +$569
ARTY
6427
iShares Future AI & Tech ETF
ARTY
$4.06B
$1K ﹤0.01%
22
PHLT
6428
DELISTED
Performant Healthcare Inc
PHLT
$1K ﹤0.01%
+577
New +$679
ACCS
6429
ACCESS Newswire
ACCS
$18.7M
$1K ﹤0.01%
+55
New +$566
TGEN
6430
Tecogen Inc
TGEN
$125M
$1K ﹤0.01%
+386
New +$1.15K
CMRX
6431
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
555
+55
+11% +$159
ATXI
6432
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
0
VIRX
6433
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1K ﹤0.01%
44
+20
+83% +$577
ORGS
6434
DELISTED
Orgenesis Inc. Common Stock
ORGS
$1K ﹤0.01%
+33
New +$1.47K
VTNR
6435
DELISTED
Vertex Energy, Inc
VTNR
$1K ﹤0.01%
+944
New +$1.24K
VBIV
6436
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1K ﹤0.01%
80
+9
+13% +$188
VERY
6437
DELISTED
Vericity, Inc. Common Stock
VERY
$1K ﹤0.01%
+100
New +$1.52K
ALPN
6438
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
357
+107
+43% +$459
CSTR
6439
DELISTED
CapStar Financial Holdings, Inc
CSTR
$1K ﹤0.01%
88
-150
-63% -$2.33K
CBAY
6440
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
131
-21
-14% -$127
BCEL
6441
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1K ﹤0.01%
+78
New +$1.19K
FGH
6442
DELISTED
FG Group Holdings Inc.
FGH
$1K ﹤0.01%
281
+181
+181% +$544
BPTH
6443
DELISTED
Bio-Path Holdings Inc
BPTH
$1K ﹤0.01%
+3
New +$745
SUNW
6444
DELISTED
Sunworks, Inc.
SUNW
$1K ﹤0.01%
348
+77
+28% +$249
ARAV
6445
DELISTED
Aravive, Inc. Common Stock
ARAV
$1K ﹤0.01%
+180
New +$1.12K
ID
6446
DELISTED
PARTS iD, Inc.
ID
$1K ﹤0.01%
100
CTG
6447
DELISTED
Computer Task Group, Inc.
CTG
$1K ﹤0.01%
+158
New +$708
FRGI
6448
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$1K ﹤0.01%
118
-145
-55% -$1.51K
SDC
6449
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$1K ﹤0.01%
+119
New +$1.99K
INFI
6450
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1K ﹤0.01%
796
+596
+298% +$812

Similar funds

Royal Bank of Canada's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

  • Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
  • Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
  • Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
  • Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
  • Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
  • Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.

Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.